API Gefitinib CAS 184475-35-2

Short Description:

Gefitinib is used to treat non-small cell lung cancer that has spread to other parts of the body in people with certain types of tumors. Gefitinib is in a class of medications called kinase inhibitors. It works by blocking the action of a certain naturally occurring substance that may be needed to help cancer cells multiply.

Contact: Erica Zheng

Email: erica@zhuoerchem.com

Tel: +86 21 2097 0332

Mob: +86 177 1767 9251

WhatsApp: +86 186 2503 6043 (WeChat & Telegram & Line)

Skype: slhyzy

Send email to us

Product Detail

Product Tags

Description

Gefitinib is used to treat lung cancer.

Specification:

Product Name	Gefitinib
Chemical Name	N-(3-Chloro-4-fluoro-phenyl)-7-methoxy-6-(3-morpholin-4-ylpropoxy)quinazolin-4-amine Gefitinib
Other Name	N-(3-Chlor-4-fluorophenyl)-7-[methoxy-6-[(3-morpholin-4-yl)propoxyl]-quinazolin-4-yl]amine;GEFITINIBRELATEDCOMPOUND;GefitinibN-(3-Chloro-4-fluoro-phenyl)-7Chemicalbook-methoxy-6-(3-morpholin-4-ylpropoxy)quinazolin-4-amine;IRESSA;GEFITINIB;n-(3-chloro-4-fluoro-phenyl)-7-methoxy-6-(3-morpholin-4-ylpropoxy)quinazolin-4-amine
CAS Number	184475-35-2
Molecular Formula	C22H24ClFN4O3
Formula Weight	446.9
Appearance	White powder
Assay	99.0% min
Melting Point	119-120 °C
Boiling Point	586.8±50.0 °C
Density	1.322±0.06 g/cm3
Package	20kg/bag/drum, 25kg/bag/drum, or as you required
Storage	Store the container tightly closed in a dry & cool place. Do not expose to direct sunlight.
COA & MSDS	Available
Application	For research purpose